Cellceutix Corporation announced that Dr. Stephen T. Sonis, D.M.D., D.M.Sc., has joined the Cellceutix Scientific Advisory Board. He currently holds appointments at the Harvard School of Dental Medicine as Professor of Oral Medicine (part-time), and is a Senior Surgeon at the Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Sonis also is a Founder and Chief Scientific Officer of Biomodels, LLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | +14.29% | -61.90% | -83.67% |
Feb. 01 | Innovation Pharmaceuticals Inc. Announces Resignation of Board Members | CI |
2023 | Alfasigma S.p.A. and Innovation Pharmaceuticals Inc. Terminate Exclusive License Agreement | CI |
1st Jan change | Capi. | |
---|---|---|
-83.67% | 423K | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- IPIX Stock
- News Innovation Pharmaceuticals Inc.
- Dr. Stephen T. Sonis Joins Scientific Advisory Board of Cellceutix Corporation